Esophageal cancer is a disease in which cells in the tissues of the esophagus — a hollow muscular tube that moves food and liquid from the throat to the stomach — become abnormal and grow and divide uncontrollably into tumors.
There will be over 20,000 estimated new cases of esophageal cancer this year, according to the American Cancer Society. Esophageal cancer is more common in men than women, and it is associated with older age, heavy alcohol use and tobacco use.
Timely and accurate detection of esophageal cancer is essential to planning the best course of treatment. After a thorough physical examination, City of Hope doctors may also use several tests to diagnose esophageal cancer and precancerous conditions such as Barrett’s esophagus.
City of Hope is an acknowledged leader in esophageal cancer research and treatment. Our extensive experience, specialized therapy protocols and extensive clinical trials program mean newly diagnosed or relapsed patients can find a treatment regimen tailored to their individual needs and gives them the best chance for survival.
U.S. News & World Reporthas rated City of Hope one of the top cancer hospitals in the country for over a decade. Our multidisciplinary team takes an integrated, comprehensive approach to diagnose and treat esophageal cancer and precancerous conditions such as Barrett’s esophagus.
Our Program Highlights:
Experience in minimally invasive, robotically assisted surgery for esophageal cancer, reducing complication risk and recovery time
Endoscopic ultrasound to accurately locate and evaluate tumors
Radiofrequency ablation to destroy tumor cells in the body
Highly precise radiation therapy
City of Hope patients have access to our comprehensive team of supportive care experts, who can help manage and treat quality-of-life issues that may come up, such as trouble eating, drinking or speaking following treatment.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Loretta Erhunmwunsee, M.D., is a thoracic surgeon and an associate professor in City of Hope's Division of Thoracic Surgery. She sees patients with lung, esophageal and mediastinal tumors. Her research focuses on eliminating health inequity in thoracic oncology patients.
Jae Y. Kim, M.D., is the chief of the Division of Thoracic Surgery and an associate professor in the Department of Surgery. Dr. Kim specializes in esophageal cancer and lung cancer, robotic surgery, mesothelioma and thymoma.
Dan Raz, M.D., M.A.S., is co-director of the Lung Cancer and Thoracic Oncology Program and an associate professor in the Division of Thoracic Surgery. Dr. Raz specializes in esophageal and lung cancer surgery – and in raising public awareness about cancer risks.